In the Pursuit of Privacy: The Promises and Predicaments of Federated Learning in Healthcare

Topaloglu, Mustafa Y.; Morrell, Elisabeth M.; Rajendran, Suraj; Topaloğlu, Ümit

doi:10.3389/frai.2021.746497

Cited by 20 publications

(6 citation statements)

References 37 publications

(43 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Alternatively, distributive learning features such as federated learning can be added to ARCliDS to overcome the small sample size issue. In federated learning approach only the model parameters are shared and data stays within the firewall of individual institutions 27 .…”

Section: Discussionmentioning

confidence: 99%

A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS)

Niraula

Sun

Jin

et al. 2023

Sci Rep

View full text Add to dashboard Cite

Involvement of many variables, uncertainty in treatment response, and inter-patient heterogeneity challenge objective decision-making in dynamic treatment regime (DTR) in oncology. Advanced machine learning analytics in conjunction with information-rich dense multi-omics data have the ability to overcome such challenges. We have developed a comprehensive artificial intelligence (AI)-based optimal decision-making framework for assisting oncologists in DTR. In this work, we demonstrate the proposed framework to Knowledge Based Response-Adaptive Radiotherapy (KBR-ART) applications by developing an interactive software tool entitled Adaptive Radiotherapy Clinical Decision Support (ARCliDS). ARCliDS is composed of two main components: Artifcial RT Environment (ARTE) and Optimal Decision Maker (ODM). ARTE is designed as a Markov decision process and modeled via supervised learning. Given a patient’s pre- and during-treatment information, ARTE can estimate treatment outcomes for a selected daily dosage value (radiation fraction size). ODM is formulated using reinforcement learning and is trained on ARTE. ODM can recommend optimal daily dosage adjustments to maximize the tumor local control probability and minimize the side effects. Graph Neural Networks (GNN) are applied to exploit the inter-feature relationships for improved modeling performance and a novel double GNN architecture is designed to avoid nonphysical treatment response. Datasets of size 117 and 292 were available from two clinical trials on adaptive RT in non-small cell lung cancer (NSCLC) patients and adaptive stereotactic body RT (SBRT) in hepatocellular carcinoma (HCC) patients, respectively. For training and validation, dense data with 297 features were available for 67 NSCLC patients and 110 features for 71 HCC patients. To increase the sample size for ODM training, we applied Generative Adversarial Networks to generate 10,000 synthetic patients. The ODM was trained on the synthetic patients and validated on the original dataset. We found that, Double GNN architecture was able to correct the nonphysical dose-response trend and improve ARCliDS recommendation. The average root mean squared difference (RMSD) between ARCliDS recommendation and reported clinical decisions using double GNNs were 0.61 [0.03] Gy/frac (mean [sem]) for adaptive RT in NSCLC patients and 2.96 [0.42] Gy/frac for adaptive SBRT HCC compared to the single GNN’s RMSDs of 0.97 [0.12] Gy/frac and 4.75 [0.16] Gy/frac, respectively. Overall, For NSCLC and HCC, ARCliDS with double GNNs was able to reproduce 36% and 50% of the good clinical decisions (local control and no side effects) and improve 74% and 30% of the bad clinical decisions, respectively. In conclusion, ARCliDS is the first web-based software dedicated to assist KBR-ART with multi-omics data. ARCliDS can learn from the reported clinical decisions and facilitate AI-assisted clinical decision-making for improving the outcomes in DTR.

show abstract

Section: Discussionmentioning

confidence: 99%

A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS)

Niraula

Sun

Jin

et al. 2023

Sci Rep

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

ARCliDS: A Clinical Decision Support System for AI-assisted Decision-Making in Response-Adaptive Radiotherapy

Niraula

Sun

Jin

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Involvement of many variables, uncertainty in treatment response, and inter-patient heterogeneity challenge objective decision-making in dynamic treatment regime (DTR) in oncology. Advanced machine learning analytics in conjunction with information-rich dense multi-omics data have the ability to overcome such challenges. We have developed a comprehensive artificial intelligence (AI)-based optimal decision-making framework for assisting oncologists in DTR. In this work, we demonstrate the proposed framework to Knowledge Based Response-Adaptive Radiotherapy (KBR-ART) applications by developing an interactive software tool entitled Adaptive Radiotherapy Clinical Decision Support (ARCliDS). Methods: ARCliDS is composed of two main components: Artificial RT Environment (ARTE) and Optimal Decision Maker (ODM). ARTE is designed as a Markov decision process and modeled via supervised learning. Given a patient's pre- and during-treatment information, ARTE can estimate treatment outcomes for a selected daily dosage value (radiation fraction size). ODM is formulated using reinforcement learning and is trained on ARTE. ODM can recommend optimal daily dosage adjustments to maximize the tumor local control probability and minimize the side effects. Graph Neural Network (GNN) is applied to exploit the inter-feature relationships for improved modeling performance and a novel double GNN architecture is designed to avoid unphysical treatment response. Datasets of size 117 and 292 were available from two clinical trials on adaptive RT in non-small cell lung cancer (NSCLC) patients and adaptive stereotactic body RT (SBRT) in hepatocellular carcinoma (HCC) patients, respectively. For training and validation, dense data with 297 features were available for 67 NSCLC patients and 110 features for 71 HCC patients. To increase the sample size for ODM training, we applied Generative Adversarial Network to generate 10,000 synthetic patients. The ODM was trained on the synthetic patients and validated on the original dataset. Results: Double GNN architecture was able to correct the unphysical dose-response trend and improve ARCliDS recommendation. The average root mean squared difference (RMSD) between ARCliDS recommendation and reported clinical decisions using double GNNs were 0.61 ± 0.03 Gy/frac (mean ± sem) for adaptive RT in NSCLC patients and 2.96±0.42 Gy/frac for adaptive SBRT HCC compared to the single GNN's RMSDs of 0.97 ± 0.12 Gy/frac and 4.75 ± 0.16 Gy/frac, respectively. Overall, For NSCLC and HCC, ARCliDS with double GNNs was able to reproduce 36% and 50% of the good clinical decisions (local control and no side effects) and improve 74% and 30% of the bad clinical decisions, respectively. Conclusion: ARCliDS is the first web-based software dedicated to assist KBR-ART with multi-omics data. ARCliDS can learn from the reported clinical decisions and facilitate AI-assisted clinical decision-making for improving the outcomes in DTR.

show abstract

“…The lack of standardized terminology regarding DQ aspects in the literature led Kahn et al in 2016 to initiate a harmonized three-category framework stating that each of these categories “conformance”, “completeness”, and “plausibility” can be interpreted in the two contexts of “verification” and “validation” [ 7 ]. Since this framework is well established and used in a large number of scientific papers [ 16 , 21 – 24 ], the development of the MIRACUM DQ software is also aligned with it. Details on the specific implementation of the various DQ categories in DQAstats are described in a previous publication of the authors [ 20 ].…”

Section: Methodsmentioning

confidence: 99%

DQAgui: a graphical user interface for the MIRACUM data quality assessment tool

Mang

Seuchter

Gülden

et al. 2022

BMC Med Inform Decis Mak

View full text Add to dashboard Cite

Background With the growing impact of observational research studies, there is also a growing focus on data quality (DQ). As opposed to experimental study designs, observational research studies are performed using data mostly collected in a non-research context (secondary use). Depending on the number of data elements to be analyzed, DQ reports of data stored within research networks can grow very large. They might be cumbersome to read and important information could be overseen quickly. To address this issue, a DQ assessment (DQA) tool with a graphical user interface (GUI) was developed and provided as a web application. Methods The aim was to provide an easy-to-use interface for users without prior programming knowledge to carry out DQ checks and to present the results in a clearly structured way. This interface serves as a starting point for a more detailed investigation of possible DQ irregularities. A user-centered development process ensured the practical feasibility of the interactive GUI. The interface was implemented in the R programming language and aligned to Kahn et al.’s DQ categories conformance, completeness and plausibility. Results With DQAgui, an R package with a web-app frontend for DQ assessment was developed. The GUI allows users to perform DQ analyses of tabular data sets and to systematically evaluate the results. During the development of the GUI, additional features were implemented, such as analyzing a subset of the data by defining time periods and restricting the analyses to certain data elements. Conclusions As part of the MIRACUM project, DQAgui is now being used at ten German university hospitals for DQ assessment and to provide a central overview of the availability of important data elements in a datamap over 2 years. Future development efforts should focus on design optimization and include a usability evaluation.

show abstract

In the Pursuit of Privacy: The Promises and Predicaments of Federated Learning in Healthcare

Cited by 20 publications

References 37 publications

A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS)

A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS)

ARCliDS: A Clinical Decision Support System for AI-assisted Decision-Making in Response-Adaptive Radiotherapy

DQAgui: a graphical user interface for the MIRACUM data quality assessment tool

Contact Info

Product

Resources

About